Literature DB >> 11911240

Interferon-gamma modulates TRAIL-mediated apoptosis in human colon carcinoma cells.

V Langaas1, S Shahzidi, J I Johnsen, B Smedsrød, B Sveinbjørnsson.   

Abstract

BACKGROUND: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is expressed by immune cells and has been shown to play an important role in tumor surveillance due to its ability to induce apoptosis in various transformed cells. Interferon gamma (IFN-gamma), a multipotent cytokine with broad stimulatory effects on anti-tumoral immune reactions, may exert its cytotoxic activity directly on tumor cells or indirectly via stimulation of effector cells. This study was designed to determine the effect of IFN-gamma on TRAIL-mediated apoptosis in human colon carcinoma cell lines.
MATERIALS AND METHODS: Cytotoxicity was assessed by MTT-assay. Expression of death receptors was measured by reverse transcriptase polymerase chain reaction. Apoptosis was assessed by caspase-8 immunoblot, DNA fragmentation and morphological studies.
RESULTS: Treatment with TRAIL resulted in detectable cytotoxicity within 5 hours and was enhanced in a dose-dependent manner. When cells were pretreated with IFN-gamma, the cytotoxic effect of TRAIL increased significantly. Treated cells showed a typical apoptotic morphology that was accompanied by internucleosomal cleavage of DNA. Up-regulation of caspase-8 expression and activation were detected as a result of pretreatment with IFN-gamma and subsequent apoptosis mediated by TRAIL.
CONCLUSION: Our results demonstrated that IFN-gamma sensitises human colon carcinoma cells to TRAIL-mediated apoptosis, partly by elevated caspase-8 expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11911240

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  14 in total

1.  Intratumoral injection of interferon-gamma gene-modified dendritic cells elicits potent antitumor effects: effective induction of tumor-specific CD8+ CTL response.

Authors:  Jianping Pan; Minghui Zhang; Jianli Wang; Qingqing Wang; Dajing Xia; Wenji Sun; Lihuang Zhang; Hai Yu; Xuetao Cao
Journal:  J Cancer Res Clin Oncol       Date:  2005-02-12       Impact factor: 4.553

2.  IL-12p40 impairs mesenchymal stem cell-mediated bone regeneration via CD4+ T cells.

Authors:  Jiajia Xu; Yiyun Wang; Jing Li; Xudong Zhang; Yiyun Geng; Yan Huang; Kerong Dai; Xiaoling Zhang
Journal:  Cell Death Differ       Date:  2016-07-29       Impact factor: 15.828

3.  Role of autophagy in the resistance to tumour necrosis factor-related apoptosis-inducing ligand-induced apoptosis in papillary and anaplastic thyroid cancer cells.

Authors:  Sang-Man Jin; Hye Won Jang; Seo Young Sohn; Na Kyung Kim; Ji Young Joung; Yoon Young Cho; Sun Wook Kim; Jae Hoon Chung
Journal:  Endocrine       Date:  2013-07-03       Impact factor: 3.633

4.  Human brain astrocytes mediate TRAIL-mediated apoptosis after treatment with IFN-gamma.

Authors:  Jeonggi Lee; Jeon-Soo Shin; In-Hong Choi
Journal:  Yonsei Med J       Date:  2006-06-30       Impact factor: 2.759

5.  Expression of TNF-related apoptosis-inducing Ligand receptors and antitumor tumor effects of TNF-related apoptosis-inducing Ligand in human hepatocellular carcinoma.

Authors:  Xiao-Ping Chen; Song-Qing He; Hai-Ping Wang; Yong-Zhong Zhao; Wan-Guang Zhang
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

6.  Interferon-gamma sensitizes resistant Ewing's sarcoma cells to tumor necrosis factor apoptosis-inducing ligand-induced apoptosis by up-regulation of caspase-8 without altering chemosensitivity.

Authors:  Andrej Lissat; Thomas Vraetz; Maria Tsokos; Ruth Klein; Matthias Braun; Nino Koutelia; Paul Fisch; Maria E Romero; Lauren Long; Peter Noellke; Crystal L Mackall; Charlotte M Niemeyer; Udo Kontny
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

7.  Modulation of inflammasome-mediated pulmonary immune activation by type I IFNs protects bone marrow homeostasis during systemic responses to Pneumocystis lung infection.

Authors:  Steve Searles; Katherine Gauss; Michelle Wilkison; Teri R Hoyt; Erin Dobrinen; Nicole Meissner
Journal:  J Immunol       Date:  2013-08-23       Impact factor: 5.422

8.  Modulation of TRAIL resistance in colon carcinoma cells: different contributions of DR4 and DR5.

Authors:  Caroline Mm van Geelen; Bodvael Pennarun; Phuong Tk Le; Elisabeth Ge de Vries; Steven de Jong
Journal:  BMC Cancer       Date:  2011-01-27       Impact factor: 4.430

9.  PhiC31/PiggyBac modified stromal stem cells: effect of interferon γ and/or tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) on murine melanoma.

Authors:  Vahid Bahrambeigi; Nafiseh Ahmadi; Stefan Moisyadi; Johann Urschitz; Rasoul Salehi; Shaghayegh Haghjooy Javanmard
Journal:  Mol Cancer       Date:  2014-11-26       Impact factor: 27.401

10.  Programmed Death Ligand 1 (PD-L1)-targeted TRAIL combines PD-L1-mediated checkpoint inhibition with TRAIL-mediated apoptosis induction.

Authors:  Djoke Hendriks; Yuan He; Iris Koopmans; Valerie R Wiersma; Robert J van Ginkel; Douwe F Samplonius; Wijnand Helfrich; Edwin Bremer
Journal:  Oncoimmunology       Date:  2016-07-06       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.